LUX HEALTH TECH ACQUISITION - COM CL A (LUXA)

CUSIP: 55068A100

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / COM CL A
Total 13F shares
23,259,172
Share change
+3,039,472
Total reported value
$228,166,000
Put/Call ratio
13%
Price per share
$9.81
Number of holders
56
Value change
+$29,765,104
Number of buys
26
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 55068A100?
CUSIP 55068A100 identifies LUXA - LUX HEALTH TECH ACQUISITION - COM CL A in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of LUX HEALTH TECH ACQUISITION - COM CL A (LUXA) as of Q3 2021

As of 30 Sep 2021, LUX HEALTH TECH ACQUISITION - COM CL A (LUXA) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,259,172 shares. The largest 10 holders included Empyrean Capital Partners, LP, Wolfswood Holdings, LLC, Weiss Asset Management LP, Senator Investment Group LP, MILLENNIUM MANAGEMENT LLC, Balyasny Asset Management LLC, MYDA Advisors LLC, Beryl Capital Management LLC, RP Investment Advisors LP, and GLAZER CAPITAL, LLC. This page lists 56 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.